Barbara Jezeršek Novaković

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Replacement Therapy

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

Therapeutics and clinical risk management

This page only lists publications with an associated author ORCID identifier.

Publications

Lučka Boltežar, Samo Rožman, Gorana Gašljević, Biljana Grčar Kuzmanov, Barbara Jezeršek Novaković
Do Double-Expressor High-Grade B-Cell Lymphomas Really Need Intensified Treatment? A Report from the Real-Life Series of High-Grade B-Cell Lymphomas Treated with Different Therapeutic Protocols at the Institute of Oncology Ljubljana. Biomedicines 12 (2) (2024)
Lučka Boltežar, Samo Rožman, Gorana Gašljević, Biljana Grčar Kuzmanov, Barbara Jezeršek Novaković
Do Double-Expressor High-Grade B-Cell Lymphomas Really Need Intensified Treatment? A Report from the Real-Life Series of High-Grade B-Cell Lymphomas Treated with Different Therapeutic Protocols at the Institute of Oncology Ljubljana. Biomedicines 12 (2) (2024)
Barbara Jezeršek Novaković, Lučka Boltežar, Aleksander Novaković
Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma. Therapeutics and clinical risk management 17 (2021)